Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.06
(-0.09%)
EUR 45.06
(-0.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.62 Billion | 2.16 Billion | 2.48 Billion | 4.23 Billion | 2.56 Billion | 2.06 Billion |
| Net Income | 499 Million | 895 Million | 1.21 Billion | 1.43 Billion | 1.43 Billion | 2.22 Billion |
| Depreciation & Amortization | 1.75 Billion | 1.83 Billion | 1.62 Billion | 1.78 Billion | 1.59 Billion | 725 Million |
| Deferred income taxes | -122.14 Million | -41.47 Million | 67.25 Million | 111.1 Million | 64.26 Million | 89.17 Million |
| Stock-based compensation | 32.51 Million | -5.87 Million | 28.29 Million | 40.89 Million | 1.99 Million | 10.74 Million |
| Change in working capital | 561.27 Million | -566 Million | -354 Million | 1.01 Billion | -465 Million | -889 Million |
| Other non-cash items | -499 Million | 46.97 Million | 1.62 Billion | 1.78 Billion | -66.25 Million | -99.91 Million |
| Investing Cash Flow | -544.22 Million | -734.72 Million | -1.19 Billion | -1.33 Billion | -3.28 Billion | -245.03 Million |
| Investments in PPE | -684.59 Million | -1.41 Billion | -1.68 Billion | -2.08 Billion | -2.23 Billion | -2.06 Billion |
| Acquisitions | 136.99 Million | 1.02 Million | -381.72 Million | -244.37 Million | -2.17 Billion | 757.7 Million |
| Investment purchases | -102.36 Million | -106 Million | -129 Million | -96 Million | -2.17 Billion | -925 Million |
| Sales/Maturities of investments | 89.59 Million | 58 Million | 144 Million | 42 Million | 1.11 Billion | -543 Thousand |
| Other Investing Activities | 16.13 Million | 723.24 Million | 853.49 Million | 1.05 Billion | 2.18 Billion | 1.98 Billion |
| Financing Cash Flow | -1.85 Billion | -1.61 Billion | -1.02 Billion | -2.66 Billion | -466.63 Million | -681.73 Million |
| Debt repayment | -1.74 Billion | -2.82 Billion | -3.4 Billion | -4.18 Billion | -4.16 Billion | -1.31 Billion |
| Dividends payments | -328.62 Million | -395.55 Million | -392.45 Million | -351.17 Million | -354.63 Million | -324.83 Million |
| Common Stock Repurchased | - | -20.15 Million | -6.51 Million | -365.98 Million | -599.79 Million | -37.22 Million |
| Common Stock Issuance | - | 20.15 Million | 6.51 Million | 2.92 Billion | 4.49 Billion | 1.52 Billion |
| Other Financing Activities | 212.46 Million | 1.6 Billion | 2.77 Billion | -693.53 Million | 153.38 Million | -528 Million |
| Accounts receivables | -151.84 Million | -46.68 Million | -163.19 Million | 71.69 Million | -64.11 Million | -170.49 Million |
| Accounts payables | 108.47 Million | -356.78 Million | -363.95 Million | 1.37 Billion | -164.76 Million | 368.39 Million |
| Inventory | -13.14 Million | -204.3 Million | -48.53 Million | -355.83 Million | -117.5 Million | -157.09 Million |
| Other working capital | 617.78 Million | 41.77 Million | 221.68 Million | -77.48 Million | -118.61 Million | -929.8 Million |
| Cash at beginning of period | 1.27 Billion | 1.48 Billion | 1.08 Billion | 1 Billion | 2.14 Billion | 978.1 Million |
| Cash at end of period | 1.42 Billion | 1.27 Billion | 1.48 Billion | 1.08 Billion | 1 Billion | 2.14 Billion |
| Capital Expenditure | -684.59 Million | -1.41 Billion | -1.68 Billion | -2.08 Billion | -2.23 Billion | -2.06 Billion |
| Effect of forex changes on cash | -72.6 Million | -23.16 Million | 131.22 Million | -160.37 Million | 47.76 Million | 32.38 Million |
| Net cash flow / Change in cash | 153.43 Million | -207.86 Million | 400.11 Million | 73.81 Million | -1.13 Billion | 1.16 Billion |
| Free Cash Flow | 1.94 Billion | 756 Million | 806 Million | 2.14 Billion | 329 Million | 2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 187.02 Million | 70.95 Million | 499 Million | 188 Million | 147.06 Million | 194.94 Million |
| Depreciation & Amortization | 383.76 Million | 512.44 Million | 1.75 Billion | 425.93 Million | 454.03 Million | 434.19 Million |
| Deferred income taxes | -46.16 Million | -44.36 Million | -122.14 Million | -32.63 Million | -30.98 Million | -36.16 Million |
| Stock-based compensation | - | - | 32.51 Million | 32.51 Million | - | - |
| Change in working capital | 113.59 Million | -420.83 Million | 561.27 Million | 122.24 Million | 328.28 Million | 448.41 Million |
| Other non-cash items | 386.77 Million | 1.22 Billion | -499 Million | -188 Million | 88.71 Million | 80.54 Million |
| Investing Cash Flow | 328.25 Million | -63.23 Million | -544.22 Million | -96.5 Million | -151.1 Million | -133.34 Million |
| Investments in PPE | -165.18 Million | -133.9 Million | -684.59 Million | -250.27 Million | -136.78 Million | -155.4 Million |
| Acquisitions | 512.99 Million | 40.57 Million | 136.99 Million | 132.51 Million | -6.58 Million | 2.99 Million |
| Investment purchases | -303 Thousand | -188 Thousand | -102.36 Million | -4.22 Million | -35.66 Million | -16.58 Million |
| Sales/Maturities of investments | -18.35 Million | 60.42 Million | 89.59 Million | 14.07 Million | 24.89 Million | 35.59 Million |
| Other Investing Activities | -892 Thousand | 65.53 Million | 16.13 Million | 11.41 Million | 3.02 Million | 63 Thousand |
| Financing Cash Flow | -843.07 Million | -294.78 Million | -1.85 Billion | -745.65 Million | -412.33 Million | -702.55 Million |
| Debt repayment | -7.96 Million | -352.01 Million | -1.74 Billion | -574.69 Million | -273.46 Million | -635.35 Million |
| Dividends payments | -349.16 Million | - | -328.62 Million | - | - | -328.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -330.18 Million | 219.34 Million | 212.46 Million | -170.95 Million | -138.87 Million | 261.41 Million |
| Accounts receivables | -10.86 Million | -552.72 Million | -151.84 Million | -75.8 Million | -48.01 Million | 328.82 Million |
| Accounts payables | 210.98 Million | -14.29 Million | 108.47 Million | -26.64 Million | 163.08 Million | -64.08 Million |
| Inventory | -15.15 Million | -40.99 Million | -13.14 Million | 42.49 Million | 55.04 Million | -22.28 Million |
| Other working capital | -71.36 Million | 187.18 Million | 617.78 Million | 182.2 Million | 158.16 Million | 205.96 Million |
| Cash at beginning of period | 1.14 Billion | 1.4 Billion | 1.27 Billion | 1.55 Billion | 1.36 Billion | 1.22 Billion |
| Cash at end of period | 1.09 Billion | 1.14 Billion | 1.42 Billion | 1.42 Billion | 1.57 Billion | 1.36 Billion |
| Capital Expenditure | -165.18 Million | -133.9 Million | -684.59 Million | -250.27 Million | -136.78 Million | -155.4 Million |
| Effect of forex changes on cash | -7.72 Million | -4.51 Million | -72.6 Million | -24.04 Million | 16.73 Million | -33.83 Million |
| Net cash flow / Change in cash | -58.04 Million | -255.49 Million | 153.43 Million | -126.02 Million | 213.06 Million | 137.4 Million |
| Free Cash Flow | 277.23 Million | -6.59 Million | 1.94 Billion | 468.78 Million | 622.97 Million | 851.73 Million |
002402
JMG
MACPLASQ
000895
A0T
WHEELS